20/11/2025
OutLine Aotearoa stands in solidarity with PATHA in their condemnation of yesterday’s decision from Minister of Health Simeon Brown introducing a ban on new prescriptions of GnRH analogues (puberty blockers) for transgender children and young people who are not currently on them.
There is plenty of evidence that supports how critical access to gender affirming healthcare is for young people.
Such as 2024 research paper from McNamara et al,
‘An Evidence-Based Critique of “The Cass Review” on Gender-affirming Care for Adolescent Gender Dysphoria.’
“Children benefit from innovative medical treatments that improve their survival and quality of life. Pediatric care would all but cease if physicians denied treatments for which the evidence base is imperfect.” (McNamara et al., 2024, p. 15)
Dr Elizabeth McElrea, GP specialist in gender affirming care and PATHA Vice-President says,
“The ban will lead to a deterioration in mental health, increased risk of suicidality and increased dysphoria in gender diverse children and young people, and will put them at a higher risk of experiencing marginalisation and discrimination.”
You can read more from PATHA through the link in our bio 🔗